Laureate Pharma has signed a biopharmaceutical development and manufacturing agreement with an undisclosed client. Laureate will develop the process to manufacture a unique Fc Fusion Protein and produce it under cGMP conditions for use in clinical trials. Terms of the agreement were not disclosed. “This project is a great fit with the experience that we have developed over the past few years working with fusion proteins,” said Robert J. Broeze, Ph. D., president and chief executiv...